NovaBay Pharmaceuticals I...

AMEX: NBY · Real-Time Price · USD
0.60
0.00 (0.00%)
At close: Jun 27, 2025, 2:57 PM
0.00%
Bid 0.6
Market Cap 3.49M
Revenue (ttm) 7.15M
Net Income (ttm) 3.66M
EPS (ttm) 24.38
PE Ratio (ttm) 0.02
Forward PE -1.55
Analyst Buy
Ask 0.61
Volume 27,779
Avg. Volume (20D) 46,670
Open 0.60
Previous Close 0.60
Day's Range 0.60 - 0.61
52-Week Range 0.36 - 2.46
Beta 0.41

About NBY

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NBY
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for NBY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
8 months ago
+18.24%
NovaBay Pharmaceuticals shares are trading higher ... Unlock content with Pro Subscription
9 months ago
+48.92%
NovaBay Pharmaceuticals shares are trading higher after the company announced it reached a definitive deal to sell its Avenova assets for $9.5 million.